Health‐related quality of life in long‐term survivors with localised prostate cancer by therapy—Results from a population‐based study

Abstract

Long-term localised PC survivors formerly treated with a combination of RP and RT or with ADT report poorer HRQoL and more symptoms than patients treated with either RP or RT alone.